An Investment Firm with Unrivaled Expertise in Regulated Industries
Washington, D.C-based private equity firm with over $8 billion of assets under management and extensive experience investing in industries that serve or are regulated by the government.
SPA, an Arlington Capital Partners Portfolio Company, Announces $47 million Strategic Expansion of Global Headquarters and Operations in Northern Virginia
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities with Acquisition of ImmunoPrecise Antibodies Europe from ImmunoPrecise Antibodies Ltd.
TEAM Technologies, an Arlington Capital Partners Portfolio Company, Expands Medical Device Manufacturing Capabilities with Acquisition of Duke Empirical, Inc.
Arlington Capital Partners Announces Launch of Verus Aerospace, a Manufacturer of Complex Aerostructure Components for the Aerospace, Defense and Space Industries
Arlington Capital Partners Announces the Formation of Keel, a New Leader in Defense Manufacturing, and its Acquisitions of Merrill Technologies Group and Metal Trades, LLC
SPA, an Arlington Capital Partners Portfolio Company, Announces $47 million Strategic Expansion of Global Headquarters and Operations in Northern Virginia
Tyto Athene, an Arlington Capital Partners Portfolio Company, Acquires stackArmor Inc. to Expand Cyber Compliance and Cloud Capabilities for Government Customers
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities with Acquisition of ImmunoPrecise Antibodies Europe from ImmunoPrecise Antibodies Ltd.
TEAM Technologies, an Arlington Capital Partners Portfolio Company, Expands Medical Device Manufacturing Capabilities with Acquisition of Duke Empirical, Inc.
